Clinical Trials Browser

OTHER × Tiragolumab × Dermatologic × Clear all

NCT05483400 2025-03-30

TIRACAN

Phase 2 Recruiting

DermatologicHead & Neck

Head and Neck Neoplasms, Melanoma

NCT05060003 2024-02-20

Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection

Phase 2 Terminated

7 enrolled 4 charts

Melanoma